Bliss GVS Pharma (NSE:BLISSGVS) EV-to-Revenue : 1.28 (As of Jun. 17, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bliss GVS Pharma's enterprise value is ₹9,845 Mil. Bliss GVS Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹7,702 Mil. Therefore, Bliss GVS Pharma's EV-to-Revenue for today is 1.28.

The historical rank and industry rank for Bliss GVS Pharma's EV-to-Revenue or its related term are showing as below:

NSE:BLISSGVS' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.99 Med: 1.82 Max: 8.28
Current: 1.28

During the past 13 years, the highest EV-to-Revenue of Bliss GVS Pharma was 8.28. The lowest was 0.99. And the median was 1.82.

NSE:BLISSGVS's EV-to-Revenue is ranked better than
71.16% of 1016 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs NSE:BLISSGVS: 1.28

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-17), Bliss GVS Pharma's stock price is ₹105.85. Bliss GVS Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹75.80. Therefore, Bliss GVS Pharma's PS Ratio for today is 1.40.

Bliss GVS Pharma EV-to-Revenue Historical Data

The historical data trend for Bliss GVS Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma EV-to-Revenue Chart

Bliss GVS Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

1.67

1.90

1.08

1.41

Bliss GVS Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															1.08	1.16	1.17	1.72	1.41

Competitive Comparison of Bliss GVS Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bliss GVS Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's EV-to-Revenue falls into.

Bliss GVS Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bliss GVS Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	9844.852	/	7702.449
	=	1.28

Bliss GVS Pharma's current Enterprise Value is ₹9,845 Mil.
Bliss GVS Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7,702 Mil.

Bliss GVS Pharma (NSE:BLISSGVS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bliss GVS Pharma's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	105.85	/	75.803
	=	1.40

Bliss GVS Pharma's share price for today is ₹105.85.
Bliss GVS Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹75.80.

Bliss GVS Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bliss GVS Pharma (NSE:BLISSGVS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » EV-to-Revenue

Traded in Other Exchanges

506197:India

Address

Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400 072

Website

https://www.blissgvs.com

Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.

Bliss GVS Pharma (NSE:BLISSGVS) Headlines

No Headlines